BIVIGAM
STN: 125389
Proper Name: Immune Globulin Intravenous (Human)
Tradename: BIVIGAM
Manufacturer: ADMA Biologics, Inc.
Indication:
- For the treatment of primary humoral immunodeficiency (PI).
Product Information
Supporting Documents
- September 11, 2023 Approval Letter - BIVIGAM
- December 7, 2022 Approval Letter - BIVIGAM
- Approval History, Letters, Reviews, and Related Documents - Bivigam
- Supporting Documents older than three years - Bivigam